Serum amyloid A levels and alpha 2 and gamma globulins on serum protein electrophoresis in cats exposed to and infected with Leishmania infantum.
Acute phase protein
Alpha 2 globulins
Feline leishmaniosis
Gamma globulins
Leishmania infantum
Phlebotomine sand flies
Serum amyloid A
Serum protein electrophoresis
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
21 Apr 2021
21 Apr 2021
Historique:
received:
19
01
2021
accepted:
31
03
2021
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
6
10
2021
Statut:
epublish
Résumé
Dogs are the main reservoir hosts of Leishmania infantum; nevertheless, recent investigations indicate a likely role for cats in the epidemiology of Leishmania infection. Feline leishmaniosis (FeL) remains poorly characterised, partly due to the lack of suitable diagnostic tools. This study aimed to compare serum amyloid A (SAA) levels and serum protein electrophoresis (SPE) profiles (specifically, alpha 2 and gamma globulins) in cats naturally exposed to or infected by L. infantum from southern Italy versus those of healthy controls and versus cats with neoplastic or inflammatory conditions from non-endemic areas. Serum or plasma samples from four cohorts of cats were analysed for SAA levels and by SPE: (i) G1: healthy controls from Leishmania-non-endemic regions of Switzerland; (ii) G2: cats pre-diagnosed with neoplastic or inflammatory conditions available from the University of Cambridge sample archive; (iii) G3: L. infantum-seropositive, quantitative (q)PCR-negative cats from southern Italy; (iv) G4: L. infantum-seropositive and qPCR-positive cats from southern Italy. SAA data were assessed for normality and homoscedasticity using the Shapiro-Wilk and Levene's tests, respectively; the Kruskall-Wallis test, followed by Dunn's test with Bonferroni correction were subsequently used to compare SAA serum levels between groups. A weighted generalised linear model with a binomial distribution was used to assess statistically significant differences in the numbers of animals displaying elevated gamma globulins and increased alpha 2 globulins between groups. Overall, 68 samples were analysed (G1: n = 16, G2: n = 20, G3: n = 20, G4: n = 12). Cats suffering from neoplastic and inflammatory conditions (G2 ) showed significantly higher SAA levels than healthy controls (G1) (median values [interquartile range]: G1: 0.00 [0.00-0.00] mg/l versus G2: 0.85 [0.00-49.55] mg/l). G2, G3 and G4 cats showed higher percentages of individuals with increased alpha 2 globulins (percentages ± standard error: G1 = 20.0% ± 10.3, G2 = 80.0% ± 8.9, G3 = 70.0% ± 10.2, G4 = 75.0% ± 12.5) and gamma globulins (G1 = 0.0% ± 0, G2 = 65.0% ± 10.7, G3 = 50.0% ± 11.2, G4 = 58.3% ± 14.2) than healthy control cats (G1). For all three markers, no significant difference between cats within G2, G3 and G4 was recorded. This study indicates that the proportions of animals with elevated levels of alpha 2 and gamma globulins are significantly higher in cats exposed to and infected with L. infantum. Levels of SAA and alpha 2 and gamma globulins may not be used to differentiate between L. infantum infection or exposure, and neoplastic and/or inflammatory conditions.
Sections du résumé
BACKGROUND
BACKGROUND
Dogs are the main reservoir hosts of Leishmania infantum; nevertheless, recent investigations indicate a likely role for cats in the epidemiology of Leishmania infection. Feline leishmaniosis (FeL) remains poorly characterised, partly due to the lack of suitable diagnostic tools. This study aimed to compare serum amyloid A (SAA) levels and serum protein electrophoresis (SPE) profiles (specifically, alpha 2 and gamma globulins) in cats naturally exposed to or infected by L. infantum from southern Italy versus those of healthy controls and versus cats with neoplastic or inflammatory conditions from non-endemic areas.
METHODS
METHODS
Serum or plasma samples from four cohorts of cats were analysed for SAA levels and by SPE: (i) G1: healthy controls from Leishmania-non-endemic regions of Switzerland; (ii) G2: cats pre-diagnosed with neoplastic or inflammatory conditions available from the University of Cambridge sample archive; (iii) G3: L. infantum-seropositive, quantitative (q)PCR-negative cats from southern Italy; (iv) G4: L. infantum-seropositive and qPCR-positive cats from southern Italy. SAA data were assessed for normality and homoscedasticity using the Shapiro-Wilk and Levene's tests, respectively; the Kruskall-Wallis test, followed by Dunn's test with Bonferroni correction were subsequently used to compare SAA serum levels between groups. A weighted generalised linear model with a binomial distribution was used to assess statistically significant differences in the numbers of animals displaying elevated gamma globulins and increased alpha 2 globulins between groups.
RESULTS
RESULTS
Overall, 68 samples were analysed (G1: n = 16, G2: n = 20, G3: n = 20, G4: n = 12). Cats suffering from neoplastic and inflammatory conditions (G2 ) showed significantly higher SAA levels than healthy controls (G1) (median values [interquartile range]: G1: 0.00 [0.00-0.00] mg/l versus G2: 0.85 [0.00-49.55] mg/l). G2, G3 and G4 cats showed higher percentages of individuals with increased alpha 2 globulins (percentages ± standard error: G1 = 20.0% ± 10.3, G2 = 80.0% ± 8.9, G3 = 70.0% ± 10.2, G4 = 75.0% ± 12.5) and gamma globulins (G1 = 0.0% ± 0, G2 = 65.0% ± 10.7, G3 = 50.0% ± 11.2, G4 = 58.3% ± 14.2) than healthy control cats (G1). For all three markers, no significant difference between cats within G2, G3 and G4 was recorded.
CONCLUSIONS
CONCLUSIONS
This study indicates that the proportions of animals with elevated levels of alpha 2 and gamma globulins are significantly higher in cats exposed to and infected with L. infantum. Levels of SAA and alpha 2 and gamma globulins may not be used to differentiate between L. infantum infection or exposure, and neoplastic and/or inflammatory conditions.
Identifiants
pubmed: 33883004
doi: 10.1186/s13071-021-04710-9
pii: 10.1186/s13071-021-04710-9
pmc: PMC8059178
doi:
Substances chimiques
Serum Amyloid A Protein
0
gamma-Globulins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
217Références
Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Med Vet Entomol. 2013;27:123–47.
doi: 10.1111/j.1365-2915.2012.01034.x
WHO (World Health Organisation). Leishmaniasis. https://www.who.int/leishmaniasis . Accessed 23 Aug 2020.
Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L. Canine leishmaniasis—new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 2008;24:324–30.
doi: 10.1016/j.pt.2008.04.001
Mendoza-Roldan J, Benelli G, Panarese R, Iatta R, Furlanello T, Beugnet F, et al. Leishmania infantum and Dirofilaria immitis infections in Italy, 2009–2019: changing distribution patterns. Parasit Vectors. 2020;13:193.
doi: 10.1186/s13071-020-04063-9
Pennisi MG, Cardoso L, Baneth G, Bourdeau P, Koutinas A, Miró G, et al. LeishVet update and recommendations on feline leishmaniosis. Parasit Vectors. 2015;8:302.
doi: 10.1186/s13071-015-0909-z
Soares CS, Duarte SC, Sousa SR. What do we know about feline leishmaniasis? J Feline Med Surg. 2016;18:435–42.
doi: 10.1177/1098612X15589358
Iatta R, Furlanello T, Colella V, Tarallo VD, Latrofa MS, Brianti E, et al. A nationwide survey of Leishmania infantum infection in cats and associated risk factors in Italy. PLoS Negl Trop Dis. 2019;13:e0007594.
doi: 10.1371/journal.pntd.0007594
Iatta R, Zatelli A, Laricchiuta P, Legrottaglie M, Modry D, Dantas-Torres F, et al. Leishmania infantum in tigers and sand flies from a leishmaniasis-endemic area, southern Italy. Emerg Infect Dis. 2020;26:1311–4.
doi: 10.3201/eid2606.191668
Pennisi MG, Lupo T, Malara D, Masucci M, Migliazzo A, Lombardo G. Serological and molecular prevalence of Leishmania infantum infection in cats from Southern Italy. J Feline Med Surg. 2012;14:656–7.
Otranto D, Napoli E, Latrofa MS, Annoscia G, Tarallo VD, Greco G, et al. Feline and canine leishmaniasis and other vector-borne diseases in the Aeolian Islands: pathogen and vector circulation in a confined environment. Vet Parasitol. 2017;236:144–51.
doi: 10.1016/j.vetpar.2017.01.019
Solano-Gallego L, Rodriguez-Cortes A, Iniesta L, Quintana J, Pastor J, Espada Y, et al. Cross-sectional serosurvey of feline leishmaniasis in ecoregions around the Northwestern Mediterranean. Am J Trop Med Hyg. 2007;76:676–80.
doi: 10.4269/ajtmh.2007.76.676
Maia C, Gomes J, Cristovão J, Nunes M, Martins A, Rebelo E, et al. Feline Leishmania infection in a canine leishmaniasis endemic region, Portugal. Vet Parasitol. 2010;174:336–40.
doi: 10.1016/j.vetpar.2010.08.030
Nasereddin A, Salant H, Abdeen Z. Feline leishmaniasis in Jerusalem: serological investigation. Vet Parasitol. 2008;158:364–9.
doi: 10.1016/j.vetpar.2008.09.022
Fernandez-Gallego A, Bernabe LF, Dalmau A, Esteban-Saltiveri D, Font A, Leiva M, et al. Feline leishmaniosis: diagnosis, treatment and outcome in 16 cats. J Feline Med Surg. 2020;22:993–1007.
doi: 10.1177/1098612X20902865
Pennisi MG, Hartmann K, Lloret A, Addie D, Belák S, Boucraut-Baralon C, et al. Leishmaniasis in cats ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:638–42.
doi: 10.1177/1098612X13489229
Paltrinieri S, Gradoni L, Roura X, Zatelli A, Zini E. Laboratory tests for diagnosing and monitoring canine leishmaniasis. Vet Clin Pathol. 2016;45:552–78.
doi: 10.1111/vcp.12413
Martínez-Subiela S, Tecles F, Parra MD, Ceron JJ. Acute phase proteins: general concepts and main clinical applications in veterinary medicine. An Vet (Murcia). 2001;17:99–116.
Eckersall PD, Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet J. 2010;185:23–7.
doi: 10.1016/j.tvjl.2010.04.009
Martínez-Subiela S, Tecles F, Eckersall PD, Ceron JJ. Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec. 2002;150:241–4.
doi: 10.1136/vr.150.8.241
Cerón JJ, Eckersall PD, Martínez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol. 2005;34:85–99.
doi: 10.1111/j.1939-165X.2005.tb00019.x
Martínez-Subiela S, Ceron JJ. Serum amyloid A levels in canine leishmaniasis. Vet Clin Pathol. 2002;31:205.
Kajikawa T, Furuta A, Onishi T, Tajima T, Sugii S. Changes in concentrations of serum amyloid A protein, alpha-1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Vet Immunol Immunopathol. 1999;68:91–8.
doi: 10.1016/S0165-2427(99)00012-4
Sasaki K, Ma Z, Khatlani T, Okuda M, Inokuma H, Onishi T. Evaluation of feline serum amyloid A (SAA) as an inflammatory marker. J Vet Med Sci. 2003;65:545–8.
doi: 10.1292/jvms.65.545
Tamamoto T, Ohno K, Ohmi A, Goto-Koshino Y, Tsujimoto H. Verification of measurement of the feline serum amyloid A (SAA) concentration by human SAA turbidimetric immunoassay and its clinical application. J Vet Med Sci. 2008;70:1247–52.
doi: 10.1292/jvms.70.1247
Vilhena H, Tvarijonaviciute A, Cerón JJ, Vieira L, Pastor J, Silvestre-Ferreira AC. Acute phase proteins response in cats naturally infected with Hepatozoon felis and Babesia vogeli. Vet Clin Pathol. 2017;46:72–6.
doi: 10.1111/vcp.12451
Cavalera MA, Iatta R, Laricchiuta P, Passantino G, Abramo F, Mendoza-Roldan JA, et al. Clinical, haematological and biochemical findings in tigers infected by Leishmania infantum. BMC Vet Res. 2020;16:214.
doi: 10.1186/s12917-020-02419-y
Taylor SS, Tappin SW, Dodkin SJ, Papasouliotis K, Casamian-Sorrosal D, Tasker S. Serum protein electrophoresis in 155 cats. J Feline Med Surg. 2010;12:643.
doi: 10.1016/j.jfms.2010.03.018
Spada E, Perego R, Vitale F, Bruno F, Castelli G, Tarantola G, et al. Feline Leishmania spp. infection in a non-endemic area of Northern Italy. Animals. 2020;10:817.
doi: 10.3390/ani10050817
Urbani L, Tirolo A, Salvatore D, Tumbarello M, Segatore S, Battilani M, et al. Serological, molecular and clinicopathological findings associated with Leishmania infantum infection in cats in Northern Italy. J Feline Med Surg. 2020;22:935–43.
doi: 10.1177/1098612X19895067
Maia C, Campino L. Biomarkers associated with Leishmania infantum exposure, infection, and disease in dogs. Front Cell Infect Microbiol. 2018;8:302.
doi: 10.3389/fcimb.2018.00302
Otranto D, Paradies P, De Capraris D, Stanneck D, Testini G, Grimm F, et al. Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic. Clin Vaccine Immunol. 2009;16:337–43.
doi: 10.1128/CVI.00268-08
Iatta R, Trerotoli P, Lucchese L, Natale A, Buonavoglia C, Nachum-Biala Y, et al. Validation of a new immunofluorescence antibody test for the detection of Leishmania infantum infection in cats. Parasitol Res. 2020;119:1381–6.
doi: 10.1007/s00436-020-06627-1
Francino O, Altet L, Sanchez-Robert E, Rodriguez A, Solano-Gallego L, Alberola J, et al. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet Parasitol. 2006;137:214–21.
doi: 10.1016/j.vetpar.2006.01.011
Gradoni L, Gramiccia M. Leishmaniasis in OIE manual of standards for diagnostic tests and vaccine. 4th ed. Paris: Office International des Epizooties; 2008. p. 803–12.